Log in to save to my catalogue

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and mu...

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and mu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6f6062b055ec425c97bc6bc4e45b233a

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)

About this item

Full title

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)

Publisher

England: EULAR

Journal title

Rheumatic & musculoskeletal diseases open, 2021-04, Vol.7 (1), p.e001546

Language

English

Formats

Publication information

Publisher

England: EULAR

More information

Scope and Contents

Contents

AimTo assess the impact of the COVID-19 pandemic on patients with rheumatic and musculoskeletal diseases (RMDs).MethodsREUMAVID is a cross-sectional study using an online survey developed by an international multidisciplinary patient-led collaboration across seven European countries targeting unselected patients with RMDs. Healthcare access, daily...

Alternative Titles

Full title

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6f6062b055ec425c97bc6bc4e45b233a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6f6062b055ec425c97bc6bc4e45b233a

Other Identifiers

ISSN

2056-5933

E-ISSN

2056-5933

DOI

10.1136/rmdopen-2020-001546

How to access this item